Mayo Clinic conducts clinical trials to improve the diagnosis and treatment of bipolar disorder. Mayo is a leader in pharmacogenomics research, the study of how genetic factors can predict a person's response to a medication. One focus of Mayo research is connecting specific genetic profiles with responses to specific antidepressant drugs used to treat bipolar disorder.
Mayo psychiatrists are working with other specialists to determine the biological basis of bipolar disorder in children and to identify better, safer and more-effective treatments for children and teens.
See a list of publications by Mayo Clinic doctors and researchers on bipolar disorder on PubMed, a service of the National Library of Medicine.